Richards, Merrill & Peterson’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
SCM
RCM
PCM
Richards, Merrill & Peterson's BCAT Position: Q1 2025 in Review
Richards, Merrill & Peterson sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2025, closing a stake of 2,000 shares — an estimated $30.3K sold.
Richards, Merrill & Peterson first reported a position in BCAT in Q4 2024 and held it in 1 quarter. The position peaked at $30.3K in Q4 2024. 92 funds tracked by Wall St. Rank hold BCAT as of Q1 2025.
- Richards, Merrill & Peterson reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2025 after selling out during the quarter.
- Richards, Merrill & Peterson sold 2,000 BlackRock Capital Allocation Term Trust shares in Q1 2025, an estimated $30.3K.
- Richards, Merrill & Peterson first reported a position in BlackRock Capital Allocation Term Trust in Q4 2024 and held it in 1 quarter.
- Richards, Merrill & Peterson's BlackRock Capital Allocation Term Trust position peaked at $30.3K in Q4 2024.
- 92 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2025.
Based on Richards, Merrill & Peterson's 13F filing for Q1 2025, filed 7 May 2025.